BIOMAT Database Logo BIOMAT Database Logo

Second malignancies following treatment for Hodgkin's disease: a Greek experience. 1994

T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second Department of Internal Medicine-Propaedeutic, Athens University, Evangelismos Hospital, Greece.

The risk and the type of second malignancies (SM) developing in 217 treated Hodgkin's disease (HD) patients were studied. The median age of the patients was 35 years (range 14-83) and the M/F ratio 1.8. Treatment consisted of radiotherapy alone (24 patients, 11%), chemotherapy alone (96 patients, 44.3%), or a combination of both modalities (43 patients, 19.8%), while 54 patients (24.9%) received salvage treatment. The median follow-up time was 67 months (range 12-224). Ten patients developed a SM with a 5-year and 10-year actuarial risk of 3.3% and 5.4%, respectively. There were 3 cases of ANLL and MDS (actuarial risk of 2.4% at 6 years), 1 case of non-Hodgkin's lymphoma and 6 cases of solid tumors (actuarial risk of 2.4% at 6 years). The risk of developing SM was higher in males and older patients (> 40 years). SM represent a serious late side effect of successful treatment for HD. The possibility of developing a SM must be taken into consideration in the initial treatment of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
June 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies after treatment for Hodgkin's disease.
January 2001, Leukemia & lymphoma,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies after Hodgkin's disease: the Munich experience.
December 1999, Annals of hematology,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies following treatment in non-Hodgkin's lymphoma.
March 1993, Leukemia & lymphoma,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
[Hodgkin's disease and second malignancies].
January 2009, Voprosy onkologii,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies in Hodgkin's disease.
June 1980, British medical journal,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Hodgkin's disease and second malignancies.
February 1993, Annals of oncology : official journal of the European Society for Medical Oncology,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies in Hodgkin's disease.
May 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies and Hodgkin's disease.
August 1987, Lancet (London, England),
T Economopoulos, and N Stathakis, and C Alexopoulos, and N Pavlidis, and M Constantinidou, and E Briassoulis, and E Papageorgiou, and J Dervenoulas, and V Pappa, and M Vaslamatzis
Second malignancies and Hodgkin's disease--the Royal Marsden Hospital experience.
March 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Copied contents to your clipboard!